Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, June 18, 2018, inter alia, to consider:a) Split/Sub-division of shares of the Companyb) Issue of bonus equity sharesc) Amendment to the Capital Clause of the Memorandum of Association, consequent to the proposed split/sub-division of shares and issue of bonus equity sharesWe wish to inform you that in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, it is hereby notified that 'Trading Window (period for trading in Company's securities) is closed from May 25, 2018 to June 20, 2018 (both days inclusive). During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's Equity Shares, either in their own name or in the name of their Immediate Relatives.Dil Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on June 18, 2018, inter alia, to consider:1. Split/Sub-division of shares of the Company.2. Issue of bonus equity shares.3. Amendment to the Capital Clause of the Memorandum of Association, consequent to the proposed split/subdivision of shares and issue of bonus equity sharesFurther, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, it is hereby notified that Trading Window (period for trading in Company's securities) is closed from May 25, 2018 to June 20, 2018 (both days inclusive). During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's Equity Shares, either in their own name or in the name of their Immediate Relatives.

Appt.of Chandraprakash Umamaheswari as Ind.Women Dir.,Jayaprakash Vishnuvardhan,Palaniswamy Sathiamoorthy,K.Chandra Prakash as Ind.Dir

We wish to inform you that the 164th Meeting of the Board of Directors of Fredun Pharmaceuticals Limited (the 'Company') is scheduled to be held on Wednesday, May 30, 2018 at 3:00 P.M. at the Registered Office of the Company interalia to consider and approve the following:1. The Audited Financial Results of the Company for the year ended 31st March 2018.2. To consider and recommend Final Dividend for the financial year ended 31st March 2018.Fredun Pharmaceuticals Ltd has informed BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2018, inter alia, to consider and approve the following:1. The Audited Financial Results of the Company for the year ended March 31, 2018.2. To consider and recommend Final Dividend for the financial year ended March 31, 2018.Further, in reference to the earlier letter dated May 15, 2018 and the Policy on Prohibition of Insider Trading of the Company; the Trading Window shall remain close from May 16, 2018 to June 02, 2018 (both days inclusive). Thus Directors / Key Managerial Personnel / Employees and their immediate Relatives are prohibited from trading in the Company's Equity Shares during the said period.We enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Wednesday,May 30, 2018; published in Navshakti & Free-press Journal on May 21, 2018.(As per BSE Announcement dated on 22/05/2018)K.P. Energy Limited submitted BSE the Newspaper Advertisement of Postal Ballot Notice and E-voting. Final Dividend (Revised) & Audited Results (Revised)(As per BSE Bulletin dated on 07/06/2018)

Appointment of Parthasarathy Iyengar, as a Company Secretary & Compliance Officer;Scheme of Amalgamation;